// App-Quantinova.ai

4079 : Genetic Abnormalities and Prognosis in Pediatric B-Precursor Acute Lymphoblastic Leukemia without Conventional Genetic Abnormalities; Tokyo Children's Cancer Study Group

Researchers

Presenter

  • Kenro Ohki

Principal Investigators

  • Shinsuke Hirabayashi

  • Akinori Yaguchi

  • Atsushi Manabe

  • Akira Ohara

  • Nobutaka Kiyokawa

  • Kazuki Terada

  • Jun Ohkubo

  • Norio Shiba

  • Motohiro Kato

  • Takashi Fukushima

  • Katsuyoshi Koh

  • Hayashi Yasuhide

Medical Centers

  • Department of Biostatistics, The University of Tokyo, Tokyo, Japan

  • Department of Hematology/Oncology, Saitama Childrens Medical Center, Saitama, Japan

  • Department of Pediatrics, St. Lukes International Hospital, Tokyo, Japan

  • Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Tokyo, Japan

  • Department of Hematology/Oncology, Saitama Childrens Medical Center, Saitama, Japan

  • Department of Child Health, Faculty of Medicine, University of Tsukuba, Ibaraki, Japan

  • Department of General Surgical Science, Gunma University Graduate School of Medicine, Maebashi, Japan

  • Department of Hematology/Oncology, Saitama Childrens Medical Center, Saitama, Japan

  • Department of Pediatric Hematology and Oncology Research, National Research Institute for Child Health and Development, Tokyo, Japan

Locations

  • Japan

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

  • Solid malignancies

Biomarkers

  • ETS transcription factor ERG

  • ETV6-RUNX1

Drug/Treatment

  • N/A

Outcome

  • N/A


Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim